PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
14-Feb-2024 medical device outsourcing market Innovative Field Activity Management Solutions: Key Players and Future Trends to 2034 Prophecy Market Insights
14-Feb-2024 Access to compressed air more convenient and cost-effective than ever before FPS Air Compressors Ltd
13-Feb-2024 Samsung Biologics awarded Leadership status by CDP for climate action efforts Samsung Biologics
13-Feb-2024 New six-figure fund to support talented individuals work across industry, academia and the NHS The Academy of Medical Sciences
13-Feb-2024 NorthEdge supports Helios Global Group complete first acquisition of HEOR and market access specialist, Cogentia, following a strong period of growth About NorthEdge 
13-Feb-2024 New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding Veeva Systems
12-Feb-2024 Novartis Cosentyx® (secukinumab) approved by SMC as the first biologic treatment in Scotland for chronic inflammatory skin condition since 2016 Novartis
12-Feb-2024 Besins Healthcare appoints new General Manager for UK & Ireland to lead continued evolution of men’s and women’s hormone health medicines Besins Healthcare UK
12-Feb-2024 Biotech start-up BugBiome secures investment for pioneering research in sustainable pest protection BugBiome
12-Feb-2024 Justin Hely to be appointed as Chief Executive Officer of GenesisCare U.K. and Europe GenesisCare U.K
09-Feb-2024 Invitation to Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs Henry Stewart Events
08-Feb-2024 InnoScot Health and Heriot-Watt University to share free MDMC guidance on achieving regulatory success InnoScot Health
08-Feb-2024 Taksa Pharmaceuticals: Pioneering Excellence in Pharma Manufacturing Taksa Pharmaceuticals
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 CHARAC SECURES INVESTMENT FROM PRIVATE EQUITY FIRM TRADITUM TO ACCELERATE ITS GROWTH IN THE UK MARKET AND INTERNATIONALLY Charac
07-Feb-2024 Exploring the Potential of AI in Personalizing Patient Care: A New Frontier in Pharmaceutical Innovation Globose Technology Solution
06-Feb-2024 Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001 Thermosome GmbH
05-Feb-2024 Breaking Boundaries in Medical Device Sterilization: 5th Edition Excellence Conference marcus evans
02-Feb-2024 Evaxion Biotech Announces Pricing of $15 Million Public Offering Evaxion Biotech